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Abstract
We studied the effects of advanced glycation end products (AGEs), which are known to ac-
cumulate in patients with diabetes, autoimmune diseases, or those who smoke, on embryonal
development. Pronuclear (PN) embryos were obtained by flushing the fallopian tubes of rats after
superovulation and mating. The cleavage rate and blastocyst yield were evaluated at 24, 72, 96,
and 120 h of culture. Glyoxal, an AGE-forming aldehyde, suppressed embryonal development at
every stage from PN to blastocyst in a concentration-dependent manner. The cleavage rate of the
embryo was also signifi cantly decreased by treatment with glyoxal at concentrations of 1 mM or
higher. The blastocyst yield was significantly decreased by treatment with glyoxal at concentra-
tions of 0.5 mM or higher. N-acetyl-L-cysteine (L-NAC) at 1 mM significantly suppressed the
glyoxal-induced embryonal toxicity. BSA-AGEs at 5 microg/ml or higher concentration signifi
cantly reduced the cleavage rate and blastocyst yield compared to those for BSA-treated embryos.
L-NAC at 1 mM significantly suppressed BSAAGE-induced embryonal toxicity. Because AGEs
are embryo-toxic, AGE contamination may influence the pregnancy rate of in vitro fertilization
and embryo transfer. AGEs, which are increased in women under pathological conditions, may
also be involved in their infertility.
KEYWORDS: advanced glycation end products, blastocyst, embryo, in vitro fertilization, N-
acetyl-L-cysteine
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dvanced glycation end products (AGEs) include 
reactive,  cross-linking molecules that are 
formed from the nonenzymatical reaction (also called 
the Maillard reaction) of reducing sugars and the 
amino groups of proteins,  lipids,  and nucleic acids.  
Plasma or serum AGEs levels are high in patients 
with hyperglycemia and/or oxidative stress such as 
diabetes,  rheumatoid arthritis,  systemic lupus erythe-
matosus (SLE),  renal insuﬃ  ciency,  or cigarette 
smoking [1ﾝ8].
　 Glyoxal,  a reactive aldehyde,  arises from enzy-
matic and nonenzymatic degradation of glucose,  lipid 
and protein catabolism,  and lipid peroxidation.  
Plasma glyoxal levels are elevated even in young,  
complication-free patients with Type 1 diabetes.  This 
aldehyde forms AGEs that react with proteins that are 
implicated in diabetic complications [9,  10].  Proteins 
reacting with glyoxals such as glyoxal and methylgly-
A
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oxal are indicative of the formation of reactive oxygen 
species (ROS).
　 Glyoxals and AGEs are also formed in various 
foodstuﬀ s during processing,  especially at high tem-
peratures.  A diet rich in AGEs is known to induce 
signiﬁ cant increases in inﬂ ammatory and endothelial 
dysfunction markers and as well as a more pronounced 
acute impairment of vascular function in type 2 diabe-
tes mellitus [11].  Heat sterilization of glucose perito-
neal dialysis ﬂ uid is known to generate glucose degra-
dation products,  which accelerate the formation of 
AGEs [12].  Formation and accumulation of AGEs in 
the peritoneum causes a deterioration of peritoneal 
permeability in patients treated using peritoneal dialy-
sis [13].
　 AGEs cause tissue injury both directly through 
phenomena such as trapping and cross-linking and indi-
rectly by binding to speciﬁ c receptors for AGEs 
(RAGEs) on the surface of various cells.  AGEs are 
known to generate ROS,  which include superoxide 
anion and hydrogen peroxide,  which cause tissue 
injury [14].
　 There have been some reports regarding the 
involvement of AGEs in reproduction.  We have 
reported that AGEs signiﬁ cantly induces apoptosis in 
human ﬁ rst-trimester trophoblasts and reduce secre-
tion of human chorionic gonadotropin [15].  These 
AGE-mediated damages in trophoblasts may lead to an 
impairment of implantation and placentation.  We have 
also observed that the levels of serum AGEs and 
accumulation of AGEs in term placenta are signiﬁ -
cantly increased in preeclamptic women compared to 
healthy pregnant women [16].  These observations 
indicate the involvement of AGEs in the oxidative 
stress of trophoblasts complicated by implantation 
failure and placental dysfunction.
　 Although AGEs adversely aﬀ ect various reproduc-
tive processes during pregnancy,  the eﬀ ects of AGEs 
on embryonal development have not yet been fully elu-
cidated.  In the present study,  we investigated the 
eﬀ ects of AGEs on the development of rat embryos.
Materials and Methods
　 Culture medium. The basic medium used for 
culture of rat pronuclear (PN) embryos was mR1ECM 
[17].  The mR1ECM was composed of 76.7 mM 
NaCl,  3.2 mM KCl,  2.0 mM CaCl2,  0.5 mM MgCl2,  
25.0 mM NaHCO3,  10.0 mM sodium lactate,  0.5 mM 
sodium pyruvate,  7.5 mM glucose,  1.0 mg/ml polyvi-
nylalcohol,  2ｵ (v/v) minimal essential medium 
(MEM) essential amino acid solution (Gibco 
Laboratories,  Grand Island,  NY,  USA),  0.1 mM 
glutamine (Sigma-Aldrich,  St.  Louis,  MO,  USA),  
and 1ｵ (v/v) MEM nonessential amino acid solution 
(Gibco) [17].  Prior to use,  the culture medium was 
covered with paraﬃ  n oil in a polystyrene culture dish 
and equilibrated with the gas phase and temperature 
(5ｵ CO2 in air at 37 °C) in a CO2 incubator for 3ﾝ
5 h.
　 Collection of rat embryos. Mature female 
Sprague-Dawley rats (2ﾝ4 months old) at proestrus,  
as assessed from vaginal smears,  were placed over-
night with mature males.  At 14:00 h on the following 
day,  the females were examined for mating by the 
presence of a vaginal plug or spermatozoa in the 
vagina.  The oviducts were isolated and placed in a dish 
containing paraﬃ  n oil,  and the culture media was 
supplemented with 0.1ｵ (w/v) hyaluronidase.  The 
cumulus-oocyte complexes were dissected out of the 
oviducts,  placed in each medium,  and freed from 
cumulus cells by repeated passage through a ﬁ ne 
pipette.  The denuded oocytes were washed 3 times 
with the culture media without hyaluronidase and 
observed for evidence of PN formation by means of a 
phase-contrast microscope.  Only PN-formed oocytes 
were transferred into 100 ｻl of the same culture 
medium and cultured under 5ｵ CO2 in air at 37 °C.
　 The experiment was carried out in accordance with 
institutional Policies and Guidelines for the Care and 
Use of Laboratory Animals.  All eﬀ orts were made to 
minimize the suﬀ ering of the rats.
　 Culture of embryos. Cleavage and blastocyst 
rates were evaluated at 24,  72,  96,  and 120 h after 
the start of culture for their development to the 
2-cell,  4-cell,  morula,  and blastocyst stages,  respec-
tively,  using a phase-contrast microscope.  Embryos 
showing blastocoele cavity formation were classiﬁ ed as 
blastocysts.
　 Preparation of BSA-AGEs. BSA-AGEs 
were prepared as previously described [15].  AGEs 
were produced by incubation of BSA (Fraction V,  
fatty acid free,  low endotoxin,  Sigma Chemical Co.,  
St.  Louis,  MO,  USA) at a concentration of 30 mg/
ml with 0.5 M glucose in 0.2 M phosphate-buﬀ ered 
saline (PBS) containing 0.5 mM EDTA,  pH 7.4,  at 
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37 °C for up to 8 weeks.  Unbound glucose was 
removed by extensive dialysis against PBS.  BSA-
AGEs were lyophilized and resuspended in PBS.  The 
density of brown color,  which is the typical physical 
appearance of AGEs,  was quantiﬁ ed by measuring the 
optical density at 405 nm.  The optical density at 
405 nm of BSA,  which was prepared under the same 
conditions without glucose,  was conﬁ rmed to be very 
low (less than 0.1) at a concentration of 3ｵ (w/v).  
The optical density at 405 nm of each batch of BSA-
AGEs was between 1.8 and 2.1 at the same concentra-
tion.  BSA-AGEs were resuspended in the culture 
medium before use.
　 Competitive enzyme-linked immunosorbent 
assay (ELISA) for AGEs. A competitive ELISA 
was carried out as previously described [16].  Each 
well of a 96-well microtiter assay plate (Immulon IB,  
Thermo Lab Systems,  Franklin,  MA,  USA) was 
coated with AGEs-modiﬁ ed bovine serum albumin 
(BSA-AGEs) in dilution buﬀ er (10-fold diluted solu-
tion of Block AceⓇ,  Dai Nippon Pharmaceutical 
Laboratories,  Osaka,  Japan) at 4 °C overnight.  
Triplicate washing with washing buﬀ er (10-fold 
diluted solution of Block AceⓇ containing 0.05ｵ 
Tween 20) was then carried out.  Each well was 
blocked with blocking buﬀ er (fourfold diluted solution 
of Block AceⓇ) at 37 °C for 1 h.
　 The mR1ECM was incubated with an equal volume 
of antibody solution (0.2 ｻg/ml,  in ﬁ nal,  anti-AGEs 
monoclonal antibody,  an antibody against an 
Nε-carboxymethyllysine-protein (CML),  TransGenic,  
Kumamoto,  Japan) at 37 °C for 1 h.  This mixture 
(100 ｻl) was transferred to an assay plate and incu-
bated at 37 °C for 1.5 h.  The wells were then washed 
3 times with washing buﬀ er.  After incubation at room 
temperature for 1 h with the horseradish peroxidase-
conjugated secondary antibody (sheep anti-mouse IgG,  
Jackson ImmunoResearch Laboratories,  West Grove,  
PA,  USA,  5000-fold dilution),  the wells were again 
washed 3 times with washing buﬀ er.  The binding of 
coated AGEs and anti-AGEs antibodies was visualized 
with o-phenylenediamine dihydrochloride (Nakalai 
Tesque,  Kyoto,  Japan).  After the reaction was 
stopped by the addition of 100 ｻl of sulfuric acid 
(1 M),  absorbance at 490 nm was read on a microplate 
reader (Model 680,  Bio-Rad,  Osaka,  Japan).
　 Statistical analysis. Statistical signiﬁ cance 
was determined by Fisher’s exact probability test.  A 
p value＜0.05 was considered statistically signiﬁ cant.
Results
　 Glyoxal,  in a concentration-dependent manner,  
suppressed cleavage of embryos at every stage from 
PN to blastocyst (Table 1).  Although 0.1 mM glyoxal 
reduced the cleavage rate and blastocyst yield com-
pared to untreated embryos,  there were no signiﬁ cant 
diﬀ erences.  The blastocyst yield was signiﬁ cantly 
decreased by treatment with glyoxal at 0.5 mM or 
higher concentrations.  The cleavage rate of embryos 
is also signiﬁ cantly decreased by treatment with gly-
oxal at concentrations of 1 mM or higher.  
Morphological changes referred to as fragmentation 
were observed in some embryos,  which were treated 
with glyoxal,  and stopped from developing (Fig.  1).
　 N-acetyl-L-cysteine (L-NAC) at 1 mM signiﬁ cantly 
suppressed glyoxal-induced embryonal toxicity (Table 
2).  However,  0.1 mM L-NAC did not show any such 
protective eﬀ ects.
　 BSA-AGEs,  in a concentration-dependent manner,  
suppressed the cleavage of embryos at every stage 
form PN to blastocyst (Table 3).  BSA-AGEs at 5
95Embryonal Toxicity of AGEsApril 2008
Table 1　 Eﬀ ects of glyoxal on rat embryonal development
Culture
(hours)
Embryonal
development
Untreated
(n ＝ 24)
Glyoxal (mM)
0.1
(n ＝ 27)
0.5
(n ＝ 29)
1
(n ＝ 20)
5
(n ＝ 20)
10
(n ＝ 12)
24 2-cell 23 (95.8%) 25 (92.6%) 27 (93.1%) 17 (85.0%) 3 (15.0%)＊ 0＊
72 4-cell 21 (87.5%) 21 (77.8%) 23 (79.3%)  9 (45.0%)＊＊ 0＊ 0＊
96 Morula 17 (70.8%) 16 (59.3%) 16 (55.2%)  2 (10.0%)＊ 0＊ 0＊
120 Blastocyst 16 (66.7%) 14 (51.9%)  6 (20.7%)＊＊＊ 0＊ 0＊ 0＊
vs｡ Untreated: ＊p＜ 0.0001，＊＊p＜ 0.005，＊＊＊p＜ 0.001
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Fig. 1　 Cytoplasmic fragmentation observed in embryos treated with glyoxal.
A,  Untreated embryos; B,  Embryos treated with glyoxal.  Arrow indicates cytosolic fragmentation.
Table 3　 Eﬀ ects of BSA-AGEs on rat embryonal development
Culture
(hours)
Embryonal
development
BSA
5 µg/ml
(n＝ 27)
BSA-AGEs (µg/ml)
1
(n＝ 23)
5
(n＝ 26)
10
(n＝ 24)
24 2-cell 26 (96.3%) 22 (95.7%) 24 (92.3%) 22 (91.7%)
72 4-cell 26 (96.3%) 19 (82.6%) 14 (53.8%)＊  4 (16.3%)＊＊
96 Morula 22 (81.5%) 13 (56.5%)＊＊＊  4 (15.4%)＊＊ 0＊＊
120 Blastocyst 16 (59.3%) 12 (52.2%) 3 (11.5%)＊ 0＊＊
vs｡ Untreated: ＊p＜ 0.0005，＊＊p＜ 0.0001，＊＊＊p＜ 0.07
Table 2　 Eﬀ ects of N-acetyl-L-cysteine on glyoxal-Induced embryonal toxicity
Culture
(hours)
Embryonal 
development
Untreated
(n＝17)
Glyoxal 1 mM
 N-acetyl-L-cysteine (mM)
(n ＝ 18)
0.1
(n ＝ 20)
1
(n ＝ 21)
24 2-cell 16 (94.1%) 16 (88.9%) 17 (85.0%) 21 (100%)
72 4-cell 12 (70.6%) 7 (38.9%) 7 (35.0%) 16 (76.2%)＊
96 Morula 12 (70.6%) 2 (11.1%) 1 ( 5.0%) 10 (47.6%)＊＊
120 Blastocyst 9 (52.9%) 0 0  8 (38.1%)＊＊＊
vs｡ Glyoxal 1 mM without N-acetyl-L-cysteine: ＊p＜ 0.03，＊＊p＜ 0.02，＊＊＊p＜ 0.005
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ｻg/ml or higher concentration signiﬁ cantly reduced 
the cleavage rate and blastocyst rate compared to 
those for BSA-treated embryos.
　 L-NAC at 1 mM signiﬁ cantly suppressed BSA-
AGEs-induced embryonal toxicity (Table 4).  L-NAC 
at 1 mM also suppressed the adverse eﬀ ects of 5 ｻg/
ml BSA-AGEs on blastocyst formation.
　 An enzyme-linked immunosorbent assay using an 
antibody against an Nε-carboxymethyllysine-protein 
and BSA-AGEs (0.1ﾝ10 ｻg/ml) as a standard revealed 
that the AGEs concentrations in mR1ECM were 
undetectable.
Discussion
　 In the present study,  we showed the adverse 
eﬀ ects of glyoxal and AGEs on embryonal develop-
ment from the PN stage to blastocyst.  Glyoxal and 
methylglyoxal are both reactive molecules that form 
AGEs reacting with proteins.  It has been reported 
that methylglyoxal interferes with the development 
from morula to blastocyst by induction of apoptosis in 
a culture system [18].  Apoptosis is induced in ﬁ rst-
trimester human trophoblasts by treatment with BSA-
AGEs [15].
　 Apoptotic morphological changes are known to be 
observed in 70ﾝ80ｵ of all in vivo or in vitro-produced 
blastocysts from mice or humans,  and in practically all 
in vivo or in vitro-produced blastocysts from cattle 
[19].  In the present study,  we observed cytoplasmic 
fragmentation in some embryos that showed arrested 
development.  These embryos contain blastomeres of 
unequal size and multiple cellular fragments,  and they 
will often show arrested development with subsequent 
degeneration.  Fragmented embryos reach the blasto-
cyst stage less frequently and are associated with 
decreased pregnancy rates [20].  Apoptosis is known 
to be responsible for fragmentation and impairment of 
early embryonic development in IVF and may result 
from suboptimal culture conditions [20].  
Fragmentation has also been observed in human 
embryos in vivo,  indicating that fragmentation may also 
reduce the quality of the embryos and cause implanta-
tion failure under pathological conditions such as dia-
betes and endometriosis [21].
　 Many animal and human studies have elucidated the 
adverse eﬀ ects of ROS on embryonal quality [22],  
although a group of investigators has reported that 
women who become pregnant by IVF have higher lev-
els of ROS than those who do not [23].  High levels of 
ROS including superoxide anion and the hydroxyl 
radical,  with hydrogen peroxide as an intermediary,  
generated by embryos or constituents in medium dur-
ing in-vitro embryo development can cause damage in 
embryos such as a rise in lipid peroxides [24] and an 
increase in protein oxidation and DNA strand breaks 
[25].  A signiﬁ cant relationship is known to be 
observed between increasing concentrations of hydro-
gen peroxide production and elevated numbers of frag-
mented embryos,  suggesting that ROS may induce 
apoptosis in embryos [26].  ROS generated from 
AGEs [14] are likely to cause embryonal fragmenta-
tion,  as observed in the present study.  RAGE is 
known to be expressed during physiological embryonic 
development [15].  The binding of AGEs to RAGE 
results in the generation of intracellular oxidative 
stress [15].  AGEs may also interfere with the pos-
sible physiological role of RAGE.
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Table 4　 Eﬀ ects of N-acetyl-L-cysteine on BSA-AGEsﾝinduced embryonal toxicity
Culture
(hours)
Embryonal
development
BSA
5 µg/ml
BSA-AGEs
5 µg/ml
BSA-AGEs
5 µg/ml
BSA
5 µg/ml
N-acetyl-L-cysteine
0
(n＝26)
N-acetyl-L-cysteine
0
(n＝23)
N-acetyl-L-cysteine
1 mM
(n＝24)
N-acetyl-L-cysteine
1 mM
(n＝21)
24 2-cell 25 (96.2%) 20 (87.0%) 22 (91.7%) 20 (95.2%)
72 4-cell 24 (92.3%) 9 (39.1%) 13 (54.2%) 20 (95.2%)
96 Morula 21 (80.8%) 5 (21.7%) 10 (41.7%) 18 (85.7%)
120 Blastocyst 15 (57.7%) 2 ( 8.7%) 9 (37.5%)＊ 14 (66.7%)
vs｡ BSA-AGEs 5 µg/ml without N-acetyl-L-cysteine: ＊p＜ 0.04
5
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　 It has been reported that methylglyoxal triggers 
apoptosis in blastocysts via activation of mitochondrial 
processes and caspases,  a route often observed during 
oxidative stress-mediated cell injury [18].  ROS gen-
erated in culture media may impact embryonal devel-
opment,  i.e.,  the cleavage rate,  blastocyst yield,  and 
quality [27].  It has been reported that curcumin,  
which is a common dietary pigment having potent anti-
oxidant eﬀ ects,  prevents methylglyoxal-induced oxida-
tive stress and apoptosis in mouse blastocysts [18].
　 In the present study,  we observed the protective 
eﬀ ects of an antioxidant,  L-NAC,  on glyoxal- or 
AGEs-induced embryotoxicity at an early stage,  from 
the PN stage.  It has been reported that chronic expo-
sure of pericytes to BSA-AGEs leads to an increase 
in apoptosis associated with an increase in cellular 
ceramide and diacylglycerol levels [28].  L-NAC 
inhibits diacylglycerol/ceramide production and pro-
tects pericytes from apoptosis [28].
　 Glyoxal is also known to cause glutathione (GSH) 
oxidation.  Glyoxal markedly increases the cytotoxic-
ity of hydrogen peroxide-induced hepatocytes and GSH 
depletion [29].  Synthesis of GSH during oocyte 
maturation has been reported in the oocytes of mouse,  
hamster,  pig,  and cattle [25].  This increase in GSH 
content provides oocytes with large glutathione stores 
available to protect embryos against ROS until the 
blastocyst stage [25].  Depletion of glutathione causes 
an increase in hydrogen peroxide.
　 L-NAC has been widely used in protection against 
the toxic eﬀ ects produced by several chemicals 
because of its radical scavenger properties and 
because L-NAC is a precursor of intracellular cyste-
ine and glutathione,  which are important intracellular 
defenses against oxidants.  L-NAC is known to have 
potential protective activities that are attributed to the 
property of a glutathione precursor against the well-
known embryotoxicity induced by methyl mercuric 
chloride in mice [30].
　 Using embryo culture media supplemented with 
anti-oxidant precursors such as ｹ-mercaptoethanol 
[31] and vitamin E [32] is known to be beneﬁ cial for 
embryonic inner cell mass (ICM) development.  
Pentoxifylline,  an inhibitor of phagocytosis and gen-
eration of toxic ROS and proteolytic enzymes,  
reduces oxidative stress-induced embryotoxicity [33].  
Cysteamine,  a glutathione synthesis enhancer,  has 
been shown to improve embryo development when 
added during in vitro maturation of bovine,  porcine,  
and ovine oocytes [34].  Various antioxidants includ-
ing these compounds may also prevent glyoxal- or 
AGEs-induced embryotoxicity.
　 We also measured the concentrations of AGEs in 
various commercially available fertilization media and 
cleavage media for human in vitro fertilization and 
embryo transfer (IVF-ET).  We detected AGEs in 
some media,  although the concentrations of AGEs in 
the media varied from lot to lot and were very low 
(equivalent to 0.2 ｻg/ml of BSA-AGEs or less).  
Bioincompatible glucose degradation products,  which 
accelerate AGEs formation,  are known to develop 
during heat sterilization of peritoneal dialysis ﬂ uids 
[12].  Trace amounts of redox-active metal ions in 
biological buﬀ ers could induce oxidative stress attrib-
uted to AGEs-proteins in vitro.  Under suboptimal 
storage conditions,  AGEs may be generated in various 
solutions,  including culture media or constituents for 
the media.  Although the concentrations of AGEs in 
the media were very low,  AGEs at these concentra-
tions may inﬂ uence embryonal development.  The serum 
concentarions of AGEs, which are evaluated based on 
the CML concentrations,  are reported to be approxi-
mately 0.6 ｻg/ml in diabetic patients [35].  The local 
concentraions of AGEs in the fallopian tubes or the 
peritoneal ﬂ uid may be higher under pathlogical condi-
tions associated with oxidative stress such as endome-
triosis or infection.
　 Further study is necessary to evaluate the patho-
logical eﬀ ects of AGEs on human embryos in vitro and 
in vivo.
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